Survival pattern of colorectal cancer in Sub-Saharan Africa: A systematic review and meta-analysis

• Published in: Cancer epidemiology 2022-12, Vol.81, p.102276-102276, Article 102276
• Main Authors: Hassen, Hamid Y., Hussien, Foziya M., Hassen, Anissa M., Dewau, Reta, Amsalu, Erkihun T., Limenih, Miteku A., Berhe, Neamin M., Kassaw, Nigussie A., Sisay, Binyam G., Manzar, Md. Dilshad
• Format: Article
• Language: English
• Subjects: Bias; Cancer; Cohort analysis; Colorectal cancer; Colorectal carcinoma; Confidence intervals; Epidemiology; Fatalities; Heterogeneity; Income; Life expectancy; Medical prognosis; Meta-analysis; Mortality; Patients; Public health; Statistical analysis; Sub-Saharan Africa; Subgroups; Survival; Systematic review
• ISSN: 1877-7821; 1877-783X
• DOI: 10.1016/j.canep.2022.102276

Cancer incidence is relatively low in sub-Saharan Africa (SSA), however, prognosis is expected to be poor in comparison with high-income countries. Comprehensive evidence is limited on the survival pattern of colorectal cancer patients in the region. We conducted a systematic review and meta-analysis to investigate the pattern of colorectal cancer survival in the region and to identify variation across countries and over time. We searched international databases MEDLINE, Scopus, Embase, Web of Science, ProQuest, CINAHL, and Google Scholar to retrieve studies that estimated survival from colorectal cancer in SSA countries from inception to December 31, 2021 without language restriction. Due to between-study heterogeneity, we performed a random-effects meta-analysis to pool survival rates. To identify study-level sources of variation, we performed subgroup analysis and meta-regression. Results are reported in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) 2020 guideline and the protocol was registered in PROSPERO database (CRD42021246935). 23 studies involving 10,031 patients were included in the review, of which, 20 were included in the meta-analysis. The meta-analysis results showed that the pooled 1-, 2-, 3-, 4-, and 5-year survival rates in SSA were 0.74 (95% CI, 0.66–0.81), 0.50 (95% CI, 0.41–0.58), 0.36 (95% CI, 0.27–0.47), 0.31 (95% CI, 0.22–0.42), and 0.28 (95% CI, 0.19–0.38) respectively. Subgroup analyses indicated that the survival rate varied according to year of study, in which those conducted in recent decades showed relatively better survival. The 5-year survival was higher in middle-income SSA countries (0.31; 95%CI: 0.17–0.49) than low-income countries (0.20; 95%CI: 0.11–0.35), however, the difference was not statistically significant. In conclusion, survival from colorectal cancer is low in sub-Saharan Africa compared to other regions. Thus, intervention strategies to improve screening, early diagnosis and treatment of colorectal cancer should be developed and implemented to improve survival in the region. [Display omitted] •The survival from colorectal cancer is low in SSA compared to other regions.•Improvement in survival is observed in recent decades, however, it is still very low in comparison with high-income regions.•Countries’ income level is associated with survival of colorectal cancer patients.